Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and Klebsiella Infections

moxifloxacin has been researched along with Klebsiella Infections in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, TY; Pai, H; Seo, MR1
Choi, MK; Fish, DN; Husain, M; Jung, R1
De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L1
García, I; Martínez-Martínez, L; Pascual, A; Rodríguez-Martínez, JM; Velasco, C1
Cars, O; Odenholt, I1

Other Studies

5 other study(ies) available for moxifloxacin and Klebsiella Infections

ArticleYear
Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Quinolones

2007
Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Colony Count, Microbial; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae Infections; Enzyme Inhibitors; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Moxifloxacin; Penicillanic Acid; Penicillins; Piperacillin; Quinolines; Tazobactam

2004
Evaluation of antibacterial in vitro activity of moxifloxacin and its effects on pulmonary clearance of Klebsiella pneumoniae in an animal experimental model.
    Arzneimittel-Forschung, 2005, Volume: 55, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Guinea Pigs; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lung; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Moxifloxacin; Quinolines

2005
Correlation of quinolone resistance levels and differences in basal and quinolone-induced expression from three qnrA-containing plasmids.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12, Issue:5

    Topics: Anti-Infective Agents; Aza Compounds; Bacterial Proteins; Blotting, Northern; Blotting, Southern; Ciprofloxacin; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Gene Dosage; Gene Expression; Humans; Klebsiella Infections; Klebsiella pneumoniae; Moxifloxacin; Plasmids; Quinolines

2006
Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5

    Topics: Animals; Anti-Infective Agents; Area Under Curve; Aza Compounds; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Horses; Humans; Injections, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pneumococcal Infections; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae

2006